Secondary Immunodeficiency

Overview

Journal Allergy Asthma Clin Immunol

Date 2025 Jan 28

PMID 39871382

Authors

Persia Pourshahnazari

Stephen D Betschel

Vy H D Kim

Susan Waserman

Rongbo Zhu

Harold Kim

Affiliations

Soon will be listed here.

Abstract

The field of medicine is constantly changing and, as healthcare providers, we are fortunate to be practicing in a time when patients are living longer and novel therapeutic options continue to evolve. However, these new advances may be associated with adverse effects that practitioners need to be aware of. Some of these impair the immune system leading to secondary immunodeficiencies (SID) that increase host susceptibility to infections and other complications. The causes and consequences of these SID are extremely broad, and a detailed review is beyond the scope of this article. The goal of this primer is to provide a general overview and understanding of common conditions and therapies leading to SID, as well as a guide to the assessment and management of patients with SID.

References

Tuano K, Seth N, Chinen J . Secondary immunodeficiencies: An overview. Ann Allergy Asthma Immunol. 2021; 127(6):617-626. DOI: 10.1016/j.anai.2021.08.413. View

Fajgenbaum D, June C . Cytokine Storm. N Engl J Med. 2020; 383(23):2255-2273. PMC: 7727315. DOI: 10.1056/NEJMra2026131. View

van den Berg J, Westerbeek E, van der Klis F, Berbers G, van Elburg R . Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev. 2010; 87(2):67-72. DOI: 10.1016/j.earlhumdev.2010.11.003. View

Weyand C, Goronzy J . Aging of the Immune System. Mechanisms and Therapeutic Targets. Ann Am Thorac Soc. 2016; 13 Suppl 5:S422-S428. PMC: 5291468. DOI: 10.1513/AnnalsATS.201602-095AW. View

Ueda M, Berger M, Gale R, Lazarus H . Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation. Blood Rev. 2017; 32(2):106-115. DOI: 10.1016/j.blre.2017.09.003. View

Sampah M, Hackam D . Dysregulated Mucosal Immunity and Associated Pathogeneses in Preterm Neonates. Front Immunol. 2020; 11:899. PMC: 7243348. DOI: 10.3389/fimmu.2020.00899. View

Wadhwa P, Morrison V . Infectious complications of chronic lymphocytic leukemia. Semin Oncol. 2006; 33(2):240-9. DOI: 10.1053/j.seminoncol.2005.12.013. View

Otani I, Lehman H, Jongco A, Tsao L, Azar A, Tarrant T . Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. J Allergy Clin Immunol. 2022; 149(5):1525-1560. DOI: 10.1016/j.jaci.2022.01.025. View

Tan L, Komarasamy T, Balasubramaniam V . Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front Immunol. 2021; 12:742941. PMC: 8515020. DOI: 10.3389/fimmu.2021.742941. View

10.

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

11.

Chandra P, Grigsby S, Philips J . Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022; 20(12):750-766. PMC: 9310001. DOI: 10.1038/s41579-022-00763-4. View

12.

Hu B, Huang S, Yin L . The cytokine storm and COVID-19. J Med Virol. 2020; 93(1):250-256. PMC: 7361342. DOI: 10.1002/jmv.26232. View

13.

Griffin D . Measles immunity and immunosuppression. Curr Opin Virol. 2020; 46:9-14. PMC: 7994291. DOI: 10.1016/j.coviro.2020.08.002. View

14.

Chauvin M, Sauce D . Mechanisms of immune aging in HIV. Clin Sci (Lond). 2022; 136(1):61-80. DOI: 10.1042/CS20210344. View

15.

Davis H, McCorkell L, Vogel J, Topol E . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21(3):133-146. PMC: 9839201. DOI: 10.1038/s41579-022-00846-2. View